Form 4: Kestra Medical Technologies Executive Receives Stock Grant
Insider Transaction (Form 4)
Timothy P. Moran, Chief Business Officer of Kestra Medical Technologies, Ltd., received 39,113 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 39,113 Common Shares on July 16, 2026; holds 81,601 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Timothy P. Moran — Officer (Chief Business Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-16 | Grant/award | Common Shares | 39,113 | — | — | 81,601 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-16 | Grant/award (39,113 shares) |
Keywords
insider transaction, Form 4, KMTS, KESTRA MEDICAL TECHNOLOGIES, LTD., neutral, Timothy P. Moran
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.